Catalog Number 19AGFN-756 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Liver Damage/Dysfunction (1954)
|
Event Date 09/11/2023 |
Event Type
Injury
|
Event Description
|
It was reported that on (b)(6) 2023, a 19mm sjm regent heart valve was implant in a patient.Perioperatively, anticoagulant drug lovenox was given to the 49-year-old patient.Treatment was interrupted for 48 hours following hepatic cytolysis.Ultrasound checks were carried out for 7 days postoperatively and showed nothing and patient patient continue to have anticoagulant.The patient have any hematologic disorders or systemic illness that could contribute to a hypercoagulability.On (b)(6) 2023, it was reported that thrombosis was detected on the valve following an ultrasound check.Evidence of dysfunction of the mechanical valve with an average gradient of 67 mmhg and iao 2/4 whereas the previous ultrasounds were unremarkable on the valvular level.Transesophageal echocardiography (tee) and cine-angiography showed one wing to be immobile and another blocked in an intermediate position.The device was explanted and a non-abbott device was implanted.The patient is stable.
|
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Manufacturer Narrative
|
An event of thrombus on the valve was confirmed.The investigation found that there was adherent calcified thrombus on the inflow and outflow surface of the mechanical heart valve leaflets and in the pivot recesses.The leaflets were immobile.There was an adherent clot on the sewing cuff.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that the patient was prescribed an anticoagulant and was compliant, with no disorders or medication which could have contributed to hypercoagulability.Treatment was interrupted for 48 hours following hepatic cytolysis.Their inr at the time of the event was normal due to the progressive dose introduction of avk treatment for 4 days with coumadin.The thrombus noted on the valve could have contributed to the immobility of the valve leaflets.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|
|
Search Alerts/Recalls
|